Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Mitsuboshi

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Infection|June 19, 2024
Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital databaseSatoru Mitsuboshi, Shungo Imai, Hayato Kizaki, et al.
Journal of Pharmaceutical Health Care and Sciences|June 8, 2024
Association between roxadustat use and suppression of thyroid function: a systematic review and meta-analysisYuki Nakano, Satoru Mitsuboshi, Kazuhiro Tada, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 1, 2022
[Association between Distigmine-induced Adverse Events and Serum Butyrylcholinesterase Level: A Multicenter Retrospective Study]Satoru Mitsuboshi, Shota Otaki, Chikashi Kaneko, et al.
Journal of Pharmaceutical Health Care and Sciences|January 29, 2016
Switching from allopurinol to febuxostat: efficacy and tolerability in hemodialysis patientsSatoru Mitsuboshi, Hitoshi Yamada, Kazuhiko Nagai, et al.
Pharmacotherapy|November 9, 2023
Comparison of different sustained-release opioids and acute respiratory conditions in patients with cancer and chronic kidney diseaseSatoru Mitsuboshi, Shungo Imai, Hayato Kizaki, et al.
British Journal of Clinical Pharmacology|December 3, 2020
Differences in risk factors for anticoagulant-related nephropathy between warfarin and direct oral anticoagulants: Analysis of the Japanese adverse drug event report databaseSatoru Mitsuboshi, Takahiro Niimura, Yoshito Zamami, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2022
Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitorShungo Imai, Satoru Mitsuboshi, Satoko Hori, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 10, 2018
[Low Continuity Rate of Sucroferric Oxyhydroxide among Japanese Hemodialysis Patients with High Phosphate Binder Pill Burden]Satoru Mitsuboshi, Hitoshi Yamada, Kazuhiko Nagai, et al.
Pharmacoepidemiology and Drug Safety|April 11, 2025
Accuracy of Diagnostic Coding for Acute Kidney Injury in Japan-Analysis of a Japanese Hospital-Based DatabaseSatoru Mitsuboshi, Shungo Imai, Masami Tsuchiya, et al.
Schizophrenia Research|November 9, 2023
Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting SystemKazumasa Kotake, Satoru Mitsuboshi, Tomonari Hosokawa, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Infection|June 19, 2024
Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital databaseSatoru Mitsuboshi, Shungo Imai, Hayato Kizaki, et al.
Journal of Pharmaceutical Health Care and Sciences|June 8, 2024
Association between roxadustat use and suppression of thyroid function: a systematic review and meta-analysisYuki Nakano, Satoru Mitsuboshi, Kazuhiro Tada, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 1, 2022
[Association between Distigmine-induced Adverse Events and Serum Butyrylcholinesterase Level: A Multicenter Retrospective Study]Satoru Mitsuboshi, Shota Otaki, Chikashi Kaneko, et al.
Journal of Pharmaceutical Health Care and Sciences|January 29, 2016
Switching from allopurinol to febuxostat: efficacy and tolerability in hemodialysis patientsSatoru Mitsuboshi, Hitoshi Yamada, Kazuhiko Nagai, et al.
Pharmacotherapy|November 9, 2023
Comparison of different sustained-release opioids and acute respiratory conditions in patients with cancer and chronic kidney diseaseSatoru Mitsuboshi, Shungo Imai, Hayato Kizaki, et al.
British Journal of Clinical Pharmacology|December 3, 2020
Differences in risk factors for anticoagulant-related nephropathy between warfarin and direct oral anticoagulants: Analysis of the Japanese adverse drug event report databaseSatoru Mitsuboshi, Takahiro Niimura, Yoshito Zamami, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2022
Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitorShungo Imai, Satoru Mitsuboshi, Satoko Hori, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 10, 2018
[Low Continuity Rate of Sucroferric Oxyhydroxide among Japanese Hemodialysis Patients with High Phosphate Binder Pill Burden]Satoru Mitsuboshi, Hitoshi Yamada, Kazuhiko Nagai, et al.
Pharmacoepidemiology and Drug Safety|April 11, 2025
Accuracy of Diagnostic Coding for Acute Kidney Injury in Japan-Analysis of a Japanese Hospital-Based DatabaseSatoru Mitsuboshi, Shungo Imai, Masami Tsuchiya, et al.
Schizophrenia Research|November 9, 2023
Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting SystemKazumasa Kotake, Satoru Mitsuboshi, Tomonari Hosokawa, et al.
Pageof 7